Executive record

Michael J. Catelani

President, Chief Operating Officer and Chief Financial Officer at Anixa Biosciences Inc

Follow
More
Challenge a Claim

Alpha ID: alpha:person:michael-j-catelaniVersion: public-0As of: 2026-09-29

Not yet claimed8 published Claims3 sources
  • Executive
  • Director

Key Claims

Biography

Seasoned executive with over 30 years of experience in finance and operations in biotechnology. Co-founded Tacere Therapeutics in 2006 and served as Chairman, President and CFO until its sale in 2012; previously held CFO roles at Benitec Biopharma and Axon Instruments.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedPresident, Chief Operating Officer and Chief Financial Officer · Anixa Biosciences Inc
  2. 2026 to end not publishedExecutive title: President, Chief Operating Officer and Chief Financial Officer · Organization not publishedANIX DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ANIX DEF 14A executive officers

    sec filing · Source published: Jan 28, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Anixa Biosciences Inc · Claim reviewed: May 15, 2026
    • Executive title: Executive title: President, Chief Operating Officer and Chief Financial Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  2. Open source

    sec def 14a · Source published: Jan 28, 2026 · Retrieved: Sep 5, 2026

    Supports 2 claims
    • Professional Role: President, Chief Operating Officer and Chief Financial Officer at Anixa Biosciences Inc · Claim reviewed: Sep 5, 2026
    • Professional Role: President, Chief Operating Officer and Chief Financial Officer at Anixa Biosciences Inc · Claim reviewed: Sep 5, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Anixa Biosciences Inc · Claim reviewed: Sep 5, 2026